Omninet Capital

Pattern Bioscience, Inc., known as Klaris Diagnostics, Inc., is a clinical diagnostics company based in Austin, Texas, that focuses on addressing antibiotic resistance. Founded in 2016, the company has developed a next-generation clinical microbiology platform utilizing its patented phenotypic single-cell technology. This innovative approach allows for rapid pathogen identification and antibiotic susceptibility testing without the lengthy culture processes typical of traditional methods. Pattern Bioscience's Digital Culture technology employs artificial intelligence and single-cell analysis, producing comprehensive and reliable diagnostic results significantly faster than the current standard of care. By integrating functional endpoints that account for various resistance mechanisms, the company aims to enhance the accuracy and efficiency of diagnoses in the fight against antibiotic-resistant infections.

Beyond Verbal, based in Tel Aviv, Israel, founded in 2012, develops cloud-based emotion analytics that derive emotions and character traits from real-time vocal intonation. Its platform measures VALENCE, AROUSAL, TEMPER, MOOD GROUPS and COMBINED EMOTIONS to help developers add emotional understanding to voice-powered devices, systems and apps. The company serves customers worldwide and its solutions are used in market research to gauge consumer emotions and attitudes toward brands, products and promotions, as well as to monitor emotional wellness and alert significant changes. Beyond Verbal also collaborates with medical institutions on clinical trials and big data projects to uncover vocal biomarkers linked to health conditions, enabling continuous remote monitoring and predictive analytics for conditions including cardiovascular, pulmonary and neurological diseases. Headquartered in Tel Aviv, the company focuses on turning speech into actionable emotional and health insights.

RADLogics is a radiology image analytics company that provides a software platform for healthcare providers and radiologists. Its AlphaPoint solution analyzes CT, MRI, ultrasound, and X-ray images using machine learning to search, measure, characterize, and generate preliminary findings reports. The platform automates detection and report generation and integrates with existing radiology workflows, leveraging clinical data to deliver case-specific analytics. The goal is to improve radiologists' accuracy and productivity and enhance patient outcomes and workflow efficiency. The company was founded in 2010 and is based in Piedmont, California.

Founded in 2008, Edeniq specializes in developing technologies for producing cellulosic ethanol from corn kernel fiber. Its Intellulose platform enables existing ethanol plants to produce additional cellulosic ethanol with zero capital investment.

The company develops code division multiple access chipsets for wireless voice and data products.

Sonics is a leading innovator in network-on-chip (NoC) technology, providing a comprehensive portfolio of intelligent on-chip communication solutions tailored for home entertainment, wireless, networking, and mobile devices. Established in 1996 and headquartered in Milpitas, California, the company specializes in streamlining complex, high-speed system-on-chip (SoC) designs by addressing memory bottlenecks and enhancing data flow within embedded systems featuring multiple cores. Sonics' silicon-proven intellectual property enables designers to create heterogeneous, multi-core SoC designs that incorporate essential subsystems for security, power, and memory, ultimately delivering high performance and energy efficiency. With its solutions, Sonics has facilitated the shipment of over 750 million units globally, solidifying its position as a vital contributor to the embedded market.

The company develops code division multiple access chipsets for wireless voice and data products.